Archives
EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1-Modified Red Fl...
EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1-Modified Red Fluorescent Reporter
Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) encodes the red fluorescent protein mCherry and features a Cap 1 structure for enhanced translation efficiency in mammalian systems (EZ Cap™ product page). The incorporation of 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP) suppresses RNA-mediated innate immune responses and extends mRNA stability (Guri-Lamce et al., 2024). The product is provided as a 996-nucleotide mRNA at ~1 mg/mL in 1 mM sodium citrate, pH 6.4, and should be stored at or below -40°C. Cap 1 capping is performed enzymatically using Vaccinia virus enzymes, replicating the natural mammalian mRNA cap. A poly(A) tail further boosts translation and mRNA longevity. This dossier details the underlying rationale, mechanism, benchmarks, and practical considerations for incorporating this advanced reporter gene mRNA into molecular workflows.
Biological Rationale
- mCherry is a monomeric red fluorescent protein derived from the sea anemone Discosoma’s DsRed, providing a well-characterized 610 nm emission for molecular imaging (FPbase).
- Messenger RNA (mRNA) reporters enable transient expression of proteins in cells without genomic integration, reducing off-target effects (Guri-Lamce et al., 2024).
- Cap 1 structure and nucleotide modifications (5mCTP, ψUTP) improve mRNA stability, translation efficiency, and minimize innate immune activation, which are critical for reproducible reporter gene experiments (EZ Cap™ product page).
- Stable, immune-evasive mRNAs like EZ Cap™ mCherry are essential for sensitive imaging, cell tracking, and quantification in molecular biology and translational research (Internal Article).
Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)
EZ Cap™ mCherry mRNA delivers a synthetic transcript encoding the 236-amino acid mCherry protein. The mRNA features a Cap 1 structure, added via Vaccinia virus Capping Enzyme (VCE), GTP, S-adenosylmethionine (SAM), and 2´-O-Methyltransferase. This cap mimics the mammalian mRNA cap, enhancing ribosome recognition and translation initiation.
- 5mCTP (5-methylcytidine triphosphate): Incorporated into the mRNA to reduce recognition by pattern recognition receptors (e.g., TLR3, RIG-I), minimizing interferon response (Guri-Lamce et al., 2024).
- ψUTP (pseudouridine triphosphate): Further suppresses innate immune activation and increases mRNA half-life in mammalian cells.
- The poly(A) tail enhances translation efficiency by promoting ribosome recycling and protecting the mRNA from exonuclease degradation.
The final transcript is approximately 996 nucleotides in length and is formulated at ~1 mg/mL in 1 mM sodium citrate buffer (pH 6.4). Storage at or below -40°C preserves integrity and activity.
Evidence & Benchmarks
- Cap 1 capping using VCE and 2´-O-Methyltransferase increases translation efficiency and mimics natural mammalian mRNA structure (Product page).
- 5mCTP and ψUTP modifications reduce innate immune sensing and subsequent cytokine production, improving protein yield and mRNA stability (Guri-Lamce et al., 2024).
- Lipid nanoparticle (LNP)–mediated delivery of modified mRNA supports efficient cytoplasmic translation and protein expression in vitro (Guri-Lamce et al., 2024).
- The mCherry protein exhibits a major excitation/emission pair at 587/610 nm, suitable for multiplexed imaging (FPbase).
- Poly(A) tailing of reporter mRNAs correlates with higher translation rates and longer mRNA half-life (Internal: Mechanistic Innovations).
Applications, Limits & Misconceptions
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is widely used as a reporter gene for:
- Tracking cellular localization and dynamics using red fluorescence.
- Comparative studies of mRNA stability and translation.
- Validation of delivery systems (e.g., LNPs, electroporation) in mammalian cells.
- Multiplexed imaging alongside other fluorescent markers.
This article extends the protocol-focused discussion in "Optimizing Fluorescent Protein Expression with mCherry mRNA" by providing molecular detail on capping and immunogenicity. For broader context on clinical/diagnostic trends, see "Redefining Reporter Gene mRNA: Mechanistic Innovations", which this article updates with new benchmark evidence. Advanced application workflows are detailed in "Applied Workflows with mCherry mRNA: Cap 1-Modified Reporter Gene"; here, we focus on foundational molecular mechanisms.
Common Pitfalls or Misconceptions
- EZ Cap™ mCherry mRNA is not suitable for stable or long-term (genomic) integration; it enables transient expression only.
- Use outside recommended storage conditions (above -40°C) can result in rapid mRNA degradation and loss of activity.
- Direct in vivo use requires an appropriate delivery vehicle; naked mRNA is rapidly degraded in biological fluids.
- Although 5mCTP and ψUTP lower immunogenicity, complete evasion of all innate immune sensors is not guaranteed in all cell types or organisms.
- mCherry fluorescence may overlap with certain red dyes or autofluorescence; proper controls are necessary for quantification.
Workflow Integration & Parameters
- Concentration & Formulation: Supplied at ~1 mg/mL in 1 mM sodium citrate, pH 6.4.
- Length: 996 nucleotides total, including 5' and 3' UTRs, coding sequence, and poly(A) tail.
- Storage: At or below -40°C is mandatory for maintaining activity.
- Transfection: Compatible with LNPs, electroporation, and cationic lipids; optimize protocols for cell type.
- Controls: Always include mock and unmodified mRNA controls to assess background and immune activation.
Conclusion & Outlook
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) sets a benchmark for reporter gene mRNA design by integrating Cap 1 capping and chemical modifications for superior translation and immune evasion (EZ Cap™ product page). Its robust performance in fluorescence-based assays and compatibility with advanced delivery systems make it an essential tool for molecular and cell biologists. Future developments may further optimize immunogenicity profiles and enable broader in vivo applications.